Conclusions First, ATP is a highly effective therapy, independent of patients characteristics.
Second, short VT cycle length and long ATP coupling intervals were identified as predictors …

Introduction Intrinsic antitachycardia pacing (iATP) is a novel automated antitachycardia
pacing (ATP) that provides individual treatment to terminate ventricular tachycardia (VT) …

Background: Anti-tachycardia pacing (ATP) delivered by implantable cardioverter
defibrillators (ICD) safely avoids painful shocks with minimum risk of tachycardia …

The incorporation of antitachycardia pacing (ATP) into implantable cardioverter defibrillators
(ICDs) has provided a better tolerated alternative to shocks. ATP has been shown to be …

Background Anti‐tachycardia pacing (ATP) delivered from an implantable device is a useful
tool to terminate ventricular tachycardia (VT). But its real‐world efficacy for those patients …

Background Anti‐tachycardia pacing (ATP) delivered from an implantable device is an
important tool to terminate ventricular tachycardia (VT). But its real‐world efficacy for fast VT …

Purpose Antitachycardia pacing (ATP) terminates the majority (but not all) of slow ventricular
tachycardias (S-VT) with a cycle length (CL)> 320 ms. Usually, several ATP therapies are …

BACKGROUND: Previous studies in implantable cardioverter-defibrillator (ICD) patients
demonstrated the efficacy and safety of antitachycardia pacing (ATP) for rapid ventricular …

Background—Implantable cardioverter-defibrillators (ICDs) reduce the risk of sudden
cardiac death. The objective of this study was to evaluate whether testing of antitachycardia …

Current guidelines recommend at least one attempt of defibrillator antitachycardia pacing
(ATP) therapy, showing preference for burst therapy. The objective of this study is to …